207_Combined course Presentations

First page Table of contents Previous page 1230 Next page Last page

DAHANCA19: Loco-regional control

control 75%

zalutumumab 68%

HR: 1.16 [95% CI: 0.84-1.60]

Pts. at risk Events

zalutumumab.

301 307 608

78 68

control

total

146

Eriksen, ICHNO 2015

Made with